JOURNEY MEDICAL CORP (DERM) Stock Cash Flow
NASDAQ:DERM - Nasdaq - US48115J1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.30M | -14.67M | -3.85M | -29.63M | -43.99M | |||
| Depreciation Amortization | 3.67M | 3.42M | 3.77M | 4.28M | 2.47M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 1.57M | |||
| Change In Working Capital | -8.34M | -3.77M | -1.66M | 6.19M | 14.71M | |||
| Interest Paid | 2.56M | 2.01M | 1.13M | 990.00K | N/A | |||
| Taxes Paid | 125.00K | 125.00K | 181.00K | 170.00K | 160.00K | |||
| Other non cash items | 6.03M | 5.89M | 6.98M | 5.63M | 23.06M | |||
| OPERATING CASH FLOW | -6.94M | -9.13M | 5.24M | -13.53M | -2.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 8.13M | 8.75M | -8.95M | 16.90M | 5.05M | |||
| Stock Issued/Repurchased | 437.00K | 416.00K | 121.00K | 140.00K | 51.51M | |||
| Other Financing Activity | 10.39M | 7.83M | 4.02M | -590.00K | -3.55M | |||
| FINANCING CASH FLOW | 18.95M | 16.99M | -4.80M | 16.46M | 53.02M | |||
| CHANGE IN CASH | -2.99M | -7.13M | -4.56M | -17.07M | 40.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.94M | -9.13M | 5.24M | -13.53M | -2.18M | |||
| Capital Expenditure | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
| FREE CASH FLOW | -21.94M | -24.13M | 240.00K | -33.53M | -12.18M | |||
All data in USD